Home/Filings/4/0001415889-15-002218
4//SEC Filing

INNOVUS PHARMACEUTICALS, INC. 4

Accession 0001415889-15-002218

CIK 0001411879operating

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 4:48 PM ET

Size

4.6 KB

Accession

0001415889-15-002218

Insider Transaction Report

Form 4
Period: 2015-06-26
Damaj Bassam
DirectorPresident and CEO10% Owner
Transactions
  • Award

    Common Stock

    2015-06-26$0.12/sh+50$66,852,322 total

Issuer

INNOVUS PHARMACEUTICALS, INC.

CIK 0001411879

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001411879

Filing Metadata

Form type
4
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 4:48 PM ET
Size
4.6 KB